Banks - Regional
Compare Stocks
5 / 10Stock Comparison
BLFY vs CHMG vs NBTB vs NFBK vs TRST
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Banks - Regional
BLFY vs CHMG vs NBTB vs NFBK vs TRST — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $275M | $331M | $2.35B | $588M | $858M |
| Revenue (TTM) | $97M | $140M | $867M | $251M | $278M |
| Net Income (TTM) | $-10M | $15M | $169M | $39M | $61M |
| Gross Margin | 48.4% | 64.2% | 72.1% | 49.1% | 67.1% |
| Operating Margin | -10.3% | 14.2% | 25.3% | 16.1% | 29.2% |
| Forward P/E | — | 9.6x | 10.8x | 10.4x | 16.9x |
| Total Debt | $324M | $5M | $327M | $760M | $193M |
| Cash & Equiv. | $53M | $23M | $185M | $168M | $51M |
BLFY vs CHMG vs NBTB vs NFBK vs TRST — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 21 | Apr 26 | Return |
|---|---|---|---|
| Blue Foundry Bancorp (BLFY) | 100 | 106.9 | +6.9% |
| Chemung Financial C… (CHMG) | 100 | 118.3 | +18.3% |
| NBT Bancorp Inc. (NBTB) | 100 | 122.2 | +22.2% |
| Northfield Bancorp,… (NFBK) | 100 | 82.3 | -17.7% |
| TrustCo Bank Corp NY (TRST) | 100 | 130.2 | +30.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BLFY vs CHMG vs NBTB vs NFBK vs TRST
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, BLFY doesn't own a clear edge in any measured category.
CHMG ranks third and is worth considering specifically for long-term compounding and sleep-well-at-night.
- 198.0% 10Y total return vs NBTB's 102.2%
- Lower volatility, beta 0.73, Low D/E 1.9%, current ratio 0.13x
- NIM 3.2% vs NFBK's 2.0%
- Beta 0.73 vs BLFY's 1.34, lower leverage
NBTB is the #2 pick in this set and the best alternative if income & stability and valuation efficiency is your priority.
- Dividend streak 12 yrs, beta 0.89, yield 3.2%
- PEG 1.53 vs TRST's 4.66
- Beta 0.89, yield 3.2%, current ratio 1.60x
- Lower P/E (10.8x vs 16.9x), PEG 1.53 vs 4.66
NFBK carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 13.9%, EPS growth -16.3%
- 13.9% NII/revenue growth vs CHMG's -6.5%
- Efficiency ratio 0.3% vs BLFY's 0.6% (lower = leaner)
- Efficiency ratio 0.3% vs BLFY's 0.6%
TRST is the clearest fit if your priority is momentum.
- +60.3% vs NBTB's +9.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 13.9% NII/revenue growth vs CHMG's -6.5% | |
| Value | Lower P/E (10.8x vs 16.9x), PEG 1.53 vs 4.66 | |
| Quality / Margins | Efficiency ratio 0.3% vs BLFY's 0.6% (lower = leaner) | |
| Stability / Safety | Beta 0.73 vs BLFY's 1.34, lower leverage | |
| Dividends | 3.2% yield, 12-year raise streak, vs NFBK's 3.7%, (1 stock pays no dividend) | |
| Momentum (1Y) | +60.3% vs NBTB's +9.0% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs BLFY's 0.6% |
BLFY vs CHMG vs NBTB vs NFBK vs TRST — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BLFY vs CHMG vs NBTB vs NFBK vs TRST — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NBTB leads in 2 of 6 categories
CHMG leads 1 • BLFY leads 0 • NFBK leads 0 • TRST leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — NBTB and TRST each lead in 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
NBTB is the larger business by revenue, generating $867M annually — 8.9x BLFY's $97M. TRST is the more profitable business, keeping 22.0% of every revenue dollar as net income compared to BLFY's -10.3%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $97M | $140M | $867M | $251M | $278M |
| EBITDAEarnings before interest/tax | -$7M | $22M | $241M | $61M | $90M |
| Net IncomeAfter-tax profit | -$10M | $15M | $169M | $39M | $61M |
| Free Cash FlowCash after capex | -$8M | $47M | $225M | $42M | $46M |
| Gross MarginGross profit ÷ Revenue | +48.4% | +64.2% | +72.1% | +49.1% | +67.1% |
| Operating MarginEBIT ÷ Revenue | -10.3% | +14.2% | +25.3% | +16.1% | +29.2% |
| Net MarginNet income ÷ Revenue | -10.3% | +10.8% | +19.5% | +11.9% | +22.0% |
| FCF MarginFCF ÷ Revenue | -8.6% | +1.4% | +25.2% | +11.9% | +16.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -46.2% | +29.8% | +39.5% | +68.8% | +44.1% |
Valuation Metrics
NBTB leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 13.5x trailing earnings, NBTB trades at a 39% valuation discount to CHMG's 22.0x P/E. Adjusting for growth (PEG ratio), NBTB offers better value at 1.92x vs TRST's 4.11x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $275M | $331M | $2.4B | $588M | $858M |
| Enterprise ValueMkt cap + debt − cash | $597M | $314M | $2.5B | $1.2B | $1000M |
| Trailing P/EPrice ÷ TTM EPS | -24.07x | 22.01x | 13.53x | 19.54x | 14.90x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 9.64x | 10.80x | 10.42x | 16.87x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.92x | — | 4.11x |
| EV / EBITDAEnterprise value multiple | — | 15.73x | 10.35x | 24.19x | 11.14x |
| Price / SalesMarket cap ÷ Revenue | 3.15x | 2.37x | 2.71x | 2.34x | 3.08x |
| Price / BookPrice ÷ Book value/share | 0.86x | 1.30x | 1.21x | 0.83x | 1.29x |
| Price / FCFMarket cap ÷ FCF | 55.84x | 163.62x | 10.75x | 19.64x | 18.75x |
Profitability & Efficiency
NBTB leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
NBTB delivers a 9.5% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-3 for BLFY. CHMG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to NFBK's 1.08x. On the Piotroski fundamental quality scale (0–9), NBTB scores 7/9 vs CHMG's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -3.1% | +6.3% | +9.5% | +5.5% | +8.9% |
| ROA (TTM)Return on assets | -0.5% | +0.5% | +1.1% | +0.7% | +1.0% |
| ROICReturn on invested capital | -1.1% | +5.0% | +7.9% | +2.0% | +7.2% |
| ROCEReturn on capital employed | -1.5% | +5.6% | +2.4% | +2.5% | +2.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 3 | 7 | 7 | 7 |
| Debt / EquityFinancial leverage | 1.04x | 0.02x | 0.17x | 1.08x | 0.28x |
| Net DebtTotal debt minus cash | $271M | -$18M | $142M | $592M | $142M |
| Cash & Equiv.Liquid assets | $53M | $23M | $185M | $168M | $51M |
| Total DebtShort + long-term debt | $324M | $5M | $327M | $760M | $193M |
| Interest CoverageEBIT ÷ Interest expense | -0.21x | 0.44x | 1.05x | 0.46x | 0.90x |
Total Returns (Dividends Reinvested)
CHMG leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CHMG five years ago would be worth $17,043 today (with dividends reinvested), compared to $10,018 for NFBK. Over the past 12 months, TRST leads with a +60.3% total return vs NBTB's +9.0%. The 3-year compound annual growth rate (CAGR) favors CHMG at 27.7% vs BLFY's 14.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +5.8% | +27.0% | +9.3% | +26.5% | +18.2% |
| 1-Year ReturnPast 12 months | +33.7% | +54.5% | +9.0% | +31.5% | +60.3% |
| 3-Year ReturnCumulative with dividends | +49.2% | +108.2% | +54.1% | +65.7% | +88.2% |
| 5-Year ReturnCumulative with dividends | +2.6% | +70.4% | +29.9% | +0.2% | +46.5% |
| 10-Year ReturnCumulative with dividends | +2.6% | +198.0% | +102.2% | +20.6% | +97.2% |
| CAGR (3Y)Annualised 3-year return | +14.3% | +27.7% | +15.5% | +18.3% | +23.5% |
Risk & Volatility
Evenly matched — CHMG and NFBK each lead in 1 of 2 comparable metrics.
Risk & Volatility
CHMG is the less volatile stock with a 0.73 beta — it tends to amplify market swings less than BLFY's 1.34 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NFBK currently trades 99.0% from its 52-week high vs BLFY's 89.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.34x | 0.73x | 0.89x | 1.00x | 0.75x |
| 52-Week HighHighest price in past year | $14.74 | $70.83 | $46.92 | $14.21 | $49.11 |
| 52-Week LowLowest price in past year | $7.61 | $43.20 | $39.20 | $9.90 | $30.17 |
| % of 52W HighCurrent price vs 52-week peak | +89.8% | +97.3% | +96.1% | +99.0% | +98.6% |
| RSI (14)Momentum oscillator 0–100 | 54.3 | 67.4 | 57.3 | 57.0 | 64.5 |
| Avg Volume (50D)Average daily shares traded | 271K | 10K | 236K | 258K | 112K |
Analyst Outlook
Evenly matched — NBTB and NFBK each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BLFY as "Hold", CHMG as "Hold", NBTB as "Hold", NFBK as "Hold", TRST as "Hold". Consensus price targets imply 3.1% upside for NFBK (target: $15) vs -27.4% for CHMG (target: $50). For income investors, NFBK offers the higher dividend yield at 3.73% vs CHMG's 1.91%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | $12.00 | $50.00 | $46.00 | $14.50 | — |
| # AnalystsCovering analysts | 3 | 7 | 10 | 9 | 3 |
| Dividend YieldAnnual dividend ÷ price | — | +1.9% | +3.2% | +3.7% | +3.1% |
| Dividend StreakConsecutive years of raises | — | 0 | 12 | 10 | 8 |
| Dividend / ShareAnnual DPS | — | $1.31 | $1.43 | $0.52 | $1.51 |
| Buyback YieldShare repurchases ÷ mkt cap | +7.1% | 0.0% | +0.4% | +3.2% | +4.4% |
NBTB leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). CHMG leads in 1 (Total Returns). 3 tied.
BLFY vs CHMG vs NBTB vs NFBK vs TRST: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BLFY or CHMG or NBTB or NFBK or TRST a better buy right now?
For growth investors, Northfield Bancorp, Inc.
(NFBK) is the stronger pick with 13. 9% revenue growth year-over-year, versus -6. 5% for Chemung Financial Corporation (CHMG). NBT Bancorp Inc. (NBTB) offers the better valuation at 13. 5x trailing P/E (10. 8x forward), making it the more compelling value choice. Analysts rate Blue Foundry Bancorp (BLFY) a "Hold" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BLFY or CHMG or NBTB or NFBK or TRST?
On trailing P/E, NBT Bancorp Inc.
(NBTB) is the cheapest at 13. 5x versus Chemung Financial Corporation at 22. 0x. On forward P/E, Chemung Financial Corporation is actually cheaper at 9. 6x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: NBT Bancorp Inc. wins at 1. 53x versus TrustCo Bank Corp NY's 4. 66x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — BLFY or CHMG or NBTB or NFBK or TRST?
Over the past 5 years, Chemung Financial Corporation (CHMG) delivered a total return of +70.
4%, compared to +0. 2% for Northfield Bancorp, Inc. (NFBK). Over 10 years, the gap is even starker: CHMG returned +198. 0% versus BLFY's +2. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BLFY or CHMG or NBTB or NFBK or TRST?
By beta (market sensitivity over 5 years), Chemung Financial Corporation (CHMG) is the lower-risk stock at 0.
73β versus Blue Foundry Bancorp's 1. 34β — meaning BLFY is approximately 83% more volatile than CHMG relative to the S&P 500. On balance sheet safety, Chemung Financial Corporation (CHMG) carries a lower debt/equity ratio of 2% versus 108% for Northfield Bancorp, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — BLFY or CHMG or NBTB or NFBK or TRST?
By revenue growth (latest reported year), Northfield Bancorp, Inc.
(NFBK) is pulling ahead at 13. 9% versus -6. 5% for Chemung Financial Corporation (CHMG). On earnings-per-share growth, the picture is similar: TrustCo Bank Corp NY grew EPS 26. 5% year-over-year, compared to -36. 9% for Chemung Financial Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BLFY or CHMG or NBTB or NFBK or TRST?
TrustCo Bank Corp NY (TRST) is the more profitable company, earning 22.
0% net margin versus -10. 3% for Blue Foundry Bancorp — meaning it keeps 22. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TRST leads at 29. 2% versus -10. 3% for BLFY. At the gross margin level — before operating expenses — NBTB leads at 72. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BLFY or CHMG or NBTB or NFBK or TRST more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, NBT Bancorp Inc. (NBTB) is the more undervalued stock at a PEG of 1. 53x versus TrustCo Bank Corp NY's 4. 66x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Chemung Financial Corporation (CHMG) trades at 9. 6x forward P/E versus 16. 9x for TrustCo Bank Corp NY — 7. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NFBK: 3. 1% to $14. 50.
08Which pays a better dividend — BLFY or CHMG or NBTB or NFBK or TRST?
In this comparison, NFBK (3.
7% yield), NBTB (3. 2% yield), TRST (3. 1% yield), CHMG (1. 9% yield) pay a dividend. BLFY does not pay a meaningful dividend and should not be held primarily for income.
09Is BLFY or CHMG or NBTB or NFBK or TRST better for a retirement portfolio?
For long-horizon retirement investors, Chemung Financial Corporation (CHMG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
73), 1. 9% yield, +198. 0% 10Y return). Both have compounded well over 10 years (CHMG: +198. 0%, BLFY: +2. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BLFY and CHMG and NBTB and NFBK and TRST?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BLFY is a small-cap quality compounder stock; CHMG is a small-cap quality compounder stock; NBTB is a small-cap deep-value stock; NFBK is a small-cap income-oriented stock; TRST is a small-cap deep-value stock. CHMG, NBTB, NFBK, TRST pay a dividend while BLFY does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.